Physiol Rev  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Rev. 83: 1017-1066, 2003; doi:10.1152/physrev.00004.2003
0031-9333/03 $15.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (339)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FREUND, T. F.
Right arrow Articles by PIOMELLI, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FREUND, T. F.
Right arrow Articles by PIOMELLI, D.

Role of Endogenous Cannabinoids in Synaptic Signaling

TAMÁS F. FREUND, ISTVÁN KATONA and DANIELE PIOMELLI

Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary; Department of Clinical Neurobiology, University Hospital of Neurology, Heidelberg, Germany; and Department of Pharmacology, University of California Irvine, Irvine, California

Freund, Tamás F., István Katona, and Daniele Piomelli. Role of Endogenous Cannabinoids in Synaptic Signaling. Physiol Rev 83: 1017–1066, 2003; 10.1152/physrev.00004.2003.—Research of cannabinoid actions was boosted in the 1990s by remarkable discoveries including identification of endogenous compounds with cannabimimetic activity (endocannabinoids) and the cloning of their molecular targets, the CB1 and CB2 receptors. Although the existence of an endogenous cannabinoid signaling system has been established for a decade, its physiological roles have just begun to unfold. In addition, the behavioral effects of exogenous cannabinoids such as delta-9-tetrahydrocannabinol, the major active compound of hashish and marijuana, await explanation at the cellular and network levels. Recent physiological, pharmacological, and high-resolution anatomical studies provided evidence that the major physiological effect of cannabinoids is the regulation of neurotransmitter release via activation of presynaptic CB1 receptors located on distinct types of axon terminals throughout the brain. Subsequent discoveries shed light on the functional consequences of this localization by demonstrating the involvement of endocannabinoids in retrograde signaling at GABAergic and glutamatergic synapses. In this review, we aim to synthesize recent progress in our understanding of the physiological roles of endocannabinoids in the brain. First, the synthetic pathways of endocannabinoids are discussed, along with the putative mechanisms of their release, uptake, and degradation. The fine-grain anatomical distribution of the neuronal cannabinoid receptor CB1 is described in most brain areas, emphasizing its general presynaptic localization and role in controlling neurotransmitter release. Finally, the possible functions of endocannabinoids as retrograde synaptic signal molecules are discussed in relation to synaptic plasticity and network activity patterns.


Address for reprint requests and other correspondence: T. F. Freund, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest 8, Szigony u.43, H-1083 Hungary (E-mail: freund{at}koki.hu).




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Zhang and C. Chen
Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation
J. Biol. Chem., August 15, 2008; 283(33): 22601 - 22611.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. D. Heifets, V. Chevaleyre, and P. E. Castillo
Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin
PNAS, July 22, 2008; 105(29): 10250 - 10255.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Huang, H. Yasuda, A. Sarihi, and T. Tsumoto
Roles of Endocannabinoids in Heterosynaptic Long-Term Depression of Excitatory Synaptic Transmission in Visual Cortex of Young Mice
J. Neurosci., July 9, 2008; 28(28): 7074 - 7083.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
S. M. Eggan, T. Hashimoto, and D. A. Lewis
Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
Arch Gen Psychiatry, July 1, 2008; 65(7): 772 - 784.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. R. Best and W. G. Regehr
Serotonin Evokes Endocannabinoid Release and Retrogradely Suppresses Excitatory Synapses
J. Neurosci., June 18, 2008; 28(25): 6508 - 6515.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. A. Edwards, L. Zhang, and B. E. Alger
Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus
PNAS, June 10, 2008; 105(23): 8142 - 8147.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Asua, A. Bilbao, M. A. Gorriti, J. A. Lopez-Moreno, M. del Mar Alvarez, M. Navarro, F. Rodriguez de Fonseca, A. Perez-Castillo, and A. Santos
Implication of the Endocannabinoid System in the Locomotor Hyperactivity Associated with Congenital Hypothyroidism
Endocrinology, May 1, 2008; 149(5): 2657 - 2666.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. O. Pimentel and T. W. Margrie
Glutamatergic transmission and plasticity between olfactory bulb mitral cells
J. Physiol., April 15, 2008; 586(8): 2107 - 2119.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. J. Sjostrom, E. A. Rancz, A. Roth, and M. Hausser
Dendritic Excitability and Synaptic Plasticity
Physiol Rev, April 1, 2008; 88(2): 769 - 840.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Ludanyi, L. Eross, S. Czirjak, J. Vajda, P. Halasz, M. Watanabe, M. Palkovits, Z. Magloczky, T. F. Freund, and I. Katona
Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus
J. Neurosci., March 19, 2008; 28(12): 2976 - 2990.
[Abstract] [Full Text] [PDF]


Home page
Learn. Mem.Home page
S. C. Azad, J. Kurz, G. Marsicano, B. Lutz, W. Zieglgansberger, and G. Rammes
Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala
Learn. Mem., March 5, 2008; 15(3): 143 - 152.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
R. W. Nesto and K. Mackie
Endocannabinoid system and its implications for obesity and cardiometabolic risk
Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B34 - B41.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Yasuda, Y. Huang, and T. Tsumoto
Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus
PNAS, February 26, 2008; 105(8): 3106 - 3111.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
M. Galarreta, F. Erdelyi, G. Szabo, and S. Hestrin
Cannabinoid Sensitivity and Synaptic Properties of 2 GABAergic Networks in the Neocortex
Cereb Cortex, January 17, 2008; (2008) bhm253v1.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Kyriakatos and A. El Manira
Long-Term Plasticity of the Spinal Locomotor Circuitry Mediated by Endocannabinoid and Nitric Oxide Signaling
J. Neurosci., November 14, 2007; 27(46): 12664 - 12674.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Telek, T. Biro, E. Bodo, B. I. Toth, I. Borbiro, G. Kunos, and R. Paus
Inhibition of human hair follicle growth by endo- and exocannabinoids
FASEB J, November 1, 2007; 21(13): 3534 - 3541.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. E. Spivak, C. R. Lupica, and M. Oz
The Endocannabinoid Anandamide Inhibits the Function of {alpha}4beta2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., October 1, 2007; 72(4): 1024 - 1032.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. K. Makara, I. Katona, G. Nyiri, B. Nemeth, C. Ledent, M. Watanabe, J. de Vente, T. F. Freund, and N. Hajos
Involvement of Nitric Oxide in Depolarization-Induced Suppression of Inhibition in Hippocampal Pyramidal Cells during Activation of Cholinergic Receptors
J. Neurosci., September 19, 2007; 27(38): 10211 - 10222.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
C. Henneberger, S. J. Redman, and R. Grantyn
Cortical Efferent Control of Subcortical Sensory Neurons by Synaptic Disinhibition
Cereb Cortex, September 1, 2007; 17(9): 2039 - 2049.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K.-M. Jung, G. Astarita, C. Zhu, M. Wallace, K. Mackie, and D. Piomelli
A Key Role for Diacylglycerol Lipase-{alpha} in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization
Mol. Pharmacol., September 1, 2007; 72(3): 612 - 621.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
E. Carter and X.-J. Wang
Cannabinoid-Mediated Disinhibition and Working Memory: Dynamical Interplay of Multiple Feedback Mechanisms in a Continuous Attractor Model of Prefrontal Cortex
Cereb Cortex, September 1, 2007; 17(suppl_1): i16 - i26.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. W. Herling, M. Gossel, G. Haschke, S. Stengelin, J. Kuhlmann, G. Muller, D. Schmoll, and W. Kramer
CB1 receptor antagonist AVE1625 affects primarily metabolic parameters independently of reduced food intake in Wistar rats
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E826 - E832.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. B. Ali
Presynaptic Inhibition of GABAA Receptor-Mediated Unitary IPSPs by Cannabinoid Receptors at Synapses Between CCK-Positive Interneurons in Rat Hippocampus
J Neurophysiol, August 1, 2007; 98(2): 861 - 869.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A.-G. Corbille, E. Valjent, G. Marsicano, C. Ledent, B. Lutz, D. Herve, and J.-A. Girault
Role of Cannabinoid Type 1 Receptors in Locomotor Activity and Striatal Signaling in Response to Psychostimulants
J. Neurosci., June 27, 2007; 27(26): 6937 - 6947.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Bifulco, C. Grimaldi, P. Gazzerro, S. Pisanti, and A. Santoro
Rimonabant: Just an Antiobesity Drug? Current Evidence on Its Pleiotropic Effects
Mol. Pharmacol., June 1, 2007; 71(6): 1445 - 1456.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
P. Berghuis, A. M. Rajnicek, Y. M. Morozov, R. A. Ross, J. Mulder, G. M. Urban, K. Monory, G. Marsicano, M. Matteoli, A. Canty, et al.
Hardwiring the Brain: Endocannabinoids Shape Neuronal Connectivity
Science, May 25, 2007; 316(5828): 1212 - 1216.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Huang, C. Acuna-Goycolea, Y. Li, H. M. Cheng, K. Obrietan, and A. N. van den Pol
Cannabinoids Excite Hypothalamic Melanin-Concentrating Hormone But Inhibit Hypocretin/Orexin Neurons: Implications for Cannabinoid Actions on Food Intake and Cognitive Arousal
J. Neurosci., May 2, 2007; 27(18): 4870 - 4881.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
Y. Hashimotodani, T. Ohno-Shosaku, and M. Kano
Endocannabinoids and Synaptic Function in the CNS
Neuroscientist, April 1, 2007; 13(2): 127 - 137.
[Abstract] [PDF]


Home page
J. Neurophysiol.Home page
E. L. Hill, T. Gallopin, I. Ferezou, B. Cauli, J. Rossier, P. Schweitzer, and B. Lambolez
Functional CB1 Receptors Are Broadly Expressed in Neocortical GABAergic and Glutamatergic Neurons
J Neurophysiol, April 1, 2007; 97(4): 2580 - 2589.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Solinas, G. Tanda, Z. Justinova, C. E. Wertheim, S. Yasar, D. Piomelli, S. K. Vadivel, A. Makriyannis, and S. R. Goldberg
The Endogenous Cannabinoid Anandamide Produces {delta}-9-Tetrahydrocannabinol-Like Discriminative and Neurochemical Effects That Are Enhanced by Inhibition of Fatty Acid Amide Hydrolase but Not by Inhibition of Anandamide Transport
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 370 - 380.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. A. McDonald, C. M. Henstridge, C. N. Connolly, and A. J. Irving
An Essential Role for Constitutive Endocytosis, but Not Activity, in the Axonal Targeting of the CB1 Cannabinoid Receptor
Mol. Pharmacol., April 1, 2007; 71(4): 976 - 984.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Turu, A. Simon, P. Gyombolai, L. Szidonya, G. Bagdy, Z. Lenkei, and L. Hunyady
The Role of Diacylglycerol Lipase in Constitutive and Angiotensin AT1 Receptor-stimulated Cannabinoid CB1 Receptor Activity
J. Biol. Chem., March 16, 2007; 282(11): 7753 - 7757.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. G. Muccioli, C. Xu, E. Odah, E. Cudaback, J. A. Cisneros, D. M. Lambert, M. L. Lopez Rodriguez, S. Bajjalieh, and N. Stella
Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells
J. Neurosci., March 14, 2007; 27(11): 2883 - 2889.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Hashimotodani, T. Ohno-Shosaku, and M. Kano
Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus
J. Neurosci., January 31, 2007; 27(5): 1211 - 1219.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Chemin, J. Nargeot, and P. Lory
Chemical Determinants Involved in Anandamide-induced Inhibition of T-type Calcium Channels
J. Biol. Chem., January 26, 2007; 282(4): 2314 - 2323.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Marsch, E. Foeller, G. Rammes, M. Bunck, M. Kossl, F. Holsboer, W. Zieglgansberger, R. Landgraf, B. Lutz, and C. T. Wotjak
Reduced Anxiety, Conditioned Fear, and Hippocampal Long-Term Potentiation in Transient Receptor Potential Vanilloid Type 1 Receptor-Deficient Mice
J. Neurosci., January 24, 2007; 27(4): 832 - 839.
[Abstract] [Full Text] [PDF]


Home page
Learn. Mem.Home page
A. F. Hoffman, M. Oz, R. Yang, A. H. Lichtman, and C. R. Lupica
Opposing actions of chronic {Delta}9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation
Learn. Mem., January 1, 2007; 14(1-2): 63 - 74.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Doyon, R. G. Denis, E.-D. Baraboi, P. Samson, J. Lalonde, Y. Deshaies, and D. Richard
Effects of Rimonabant (SR141716) on Fasting-Induced Hypothalamic-Pituitary-Adrenal Axis and Neuronal Activation in Lean and Obese Zucker Rats
Diabetes, December 1, 2006; 55(12): 3403 - 3410.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. Szabo, M. J. Urbanski, T. Bisogno, V. D. Marzo, A. Mendiguren, W. U. Baer, and I. Freiman
Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol
J. Physiol., November 15, 2006; 577(1): 263 - 280.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
N. Sang and C. Chen
Lipid Signaling and Synaptic Plasticity
Neuroscientist, October 1, 2006; 12(5): 425 - 434.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
A. Degroot, A. Kofalvi, M. R. Wade, R. J. Davis, R. J. Rodrigues, N. Rebola, R. A. Cunha, and G. G. Nomikos
CB1 Receptor Antagonism Increases Hippocampal Acetylcholine Release: Site and Mechanism of Action
Mol. Pharmacol., October 1, 2006; 70(4): 1236 - 1245.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. S. Graham, N. Ball, E. L. Scotter, P. Narayan, M. Dragunow, and M. Glass
Induction of Krox-24 by Endogenous Cannabinoid Type 1 Receptors in Neuro2A Cells Is Mediated by the MEK-ERK MAPK Pathway and Is Suppressed by the Phosphatidylinositol 3-Kinase Pathway
J. Biol. Chem., September 29, 2006; 281(39): 29085 - 29095.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
I. Freiman, A. Anton, H. Monyer, M. J. Urbanski, and B. Szabo
Analysis of the effects of cannabinoids on identified synaptic connections in the caudate-putamen by paired recordings in transgenic mice
J. Physiol., September 15, 2006; 575(3): 789 - 806.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Pacher, S. Batkai, and G. Kunos
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Kishimoto and M. Kano
Endogenous Cannabinoid Signaling through the CB1 Receptor Is Essential for Cerebellum-Dependent Discrete Motor Learning.
J. Neurosci., August 23, 2006; 26(34): 8829 - 8837.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. Wettschureck, M. van der Stelt, H. Tsubokawa, H. Krestel, A. Moers, S. Petrosino, G. Schutz, V. Di Marzo, and S. Offermanns
Forebrain-Specific Inactivation of Gq/G11 Family G Proteins Results in Age-Dependent Epilepsy and Impaired Endocannabinoid Formation
Mol. Cell. Biol., August 1, 2006; 26(15): 5888 - 5894.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. Wang, S. K. Dey, and M. Maccarrone
Jekyll and Hyde: Two Faces of Cannabinoid Signaling in Male and Female Fertility
Endocr. Rev., August 1, 2006; 27(5): 427 - 448.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Patel and C. J. Hillard
Pharmacological Evaluation of Cannabinoid Receptor Ligands in a Mouse Model of Anxiety: Further Evidence for an Anxiolytic Role for Endogenous Cannabinoid Signaling
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 304 - 311.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Kamprath, G. Marsicano, J. Tang, K. Monory, T. Bisogno, V. D. Marzo, B. Lutz, and C. T. Wotjak
Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes.
J. Neurosci., June 21, 2006; 26(25): 6677 - 6686.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. D. Brenowitz, A. R. Best, and W. G. Regehr
Sustained elevation of dendritic calcium evokes widespread endocannabinoid release and suppression of synapses onto cerebellar Purkinje cells.
J. Neurosci., June 21, 2006; 26(25): 6841 - 6850.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Katona, G. M. Urban, M. Wallace, C. Ledent, K.-M. Jung, D. Piomelli, K. Mackie, and T. F. Freund
Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses
J. Neurosci., May 24, 2006; 26(21): 5628 - 5637.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. R. Domenici, S. C. Azad, G. Marsicano, A. Schierloh, C. T. Wotjak, H.-U. Dodt, W. Zieglgansberger, B. Lutz, and G. Rammes
Cannabinoid Receptor Type 1 Located on Presynaptic Terminals of Principal Neurons in the Forebrain Controls Glutamatergic Synaptic Transmission
J. Neurosci., May 24, 2006; 26(21): 5794 - 5799.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. A. Rancz and M. Hausser
Dendritic calcium spikes are tunable triggers of cannabinoid release and short-term synaptic plasticity in cerebellar Purkinje neurons.
J. Neurosci., May 17, 2006; 26(20): 5428 - 5437.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Isokawa and B. E. Alger
Ryanodine Receptor Regulates Endogenous Cannabinoid Mobilization in the Hippocampus
J Neurophysiol, May 1, 2006; 95(5): 3001 - 3011.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. Sang, J. Zhang, and C. Chen
PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons
J. Physiol., May 1, 2006; 572(3): 735 - 745.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. A. Bender, K. J. Bender, D. J. Brasier, and D. E. Feldman
Two coincidence detectors for spike timing-dependent plasticity in somatosensory cortex.
J. Neurosci., April 19, 2006; 26(16): 4166 - 4177.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Witting, L. Chen, E. Cudaback, A. Straiker, L. Walter, B. Rickman, T. Moller, C. Brosnan, and N. Stella
From the Cover: Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection
PNAS, April 18, 2006; 103(16): 6362 - 6367.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Kawamura, M. Fukaya, T. Maejima, T. Yoshida, E. Miura, M. Watanabe, T. Ohno-Shosaku, and M. Kano
The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.
J. Neurosci., March 15, 2006; 26(11): 2991 - 3001.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
U. Pagotto, G. Marsicano, D. Cota, B. Lutz, and R. Pasquali
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Endocr. Rev., February 1, 2006; 27(1): 73 - 100.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Engler, I. Freiman, M. Urbanski, an